Molecular Biological Research for Hereditary Retinal Degeneration
遗传性视网膜变性的分子生物学研究
基本信息
- 批准号:01480413
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hereditary retinal degeneration is a group of disorders, whose causes have been obscure. Because of the unknown nature, we have not had effective modalities of treatment. Many ophthalmic researchers have ever studied this group of disorders by means of morphologic, biochemical or physiological methods. However, because the essential abnormalities of these disorders are in genes which we have not fully understood yet, we have not known the pathogenesis of these diseases. Since most patients with these diseases show symptomes and abnormal findings only in the retinochoroidal region while other parts of the body are within normal range, proteins specifically produced within the retina are suspected to be genetically altered.In order to obtain clues to understand genetic nature of the hereditary retinal degeneration, cDNA clones for retina specific proteins were examined. As the first step, cDNA clones for rhodopsin, Irbp, Cralbp, transducin (alpha-subunit), retinal S-antigen and 33kDa protein were obtained and transfeccted into E. coli JM109. Also, experiments were prepared for isolation of novel cDNA clones for some of unknown retina specific proteins.As the second step of this project, genomic DNA's from patients with retinitis pigmentosa were examined with a particular interest on the rhodopsin gene using polymerase chain reaction and restriction fragment length polymorphism. As a result, two cases of the same pedigree with autosomal dominant retinitis pigmentosa was found to have a point mutation in the rhodopsin gene, suggesting that rhodopsin gene could be related to the pathogenesis of a certain kind of retinitis pigmentosa.
遗传性视网膜变性是一组病因不明的疾病。由于性质不明,我们没有有效的治疗方法。许多眼科研究者曾从形态学、生物化学或生理学的角度对这组疾病进行了研究。然而,由于这些疾病的基本异常存在于我们尚未完全了解的基因中,因此我们还不知道这些疾病的发病机制。由于大多数患有这些疾病的患者仅在视网膜脉络膜区域表现出病变和异常结果,而身体的其他部位在正常范围内,因此怀疑视网膜内特异性产生的蛋白质发生了遗传改变。为了获得了解遗传性视网膜变性的遗传本质的线索,检查了视网膜特异性蛋白质的cDNA克隆。第一步,获得视紫红质、Irbp、Cralbp、转导素α亚基、视网膜S抗原和33kDa蛋白的cDNA克隆,并转染E. coli JM 109。作为本项目的第二步,我们利用聚合酶链反应和限制性片段长度多态性技术,对视网膜色素变性患者的基因组DNA进行了研究,特别是对视紫红质基因进行了研究。结果发现同一个常染色体显性遗传视网膜色素变性家系的2例患者存在视紫红质基因点突变,提示视紫红质基因可能与某种视网膜色素变性的发病有关。
项目成果
期刊论文数量(60)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tamai,M.,et al.: "A collection system to obtain vitreous humor in clinical cases" Archives of Ophthalmology. 109. (1991)
Tamai,M.,et al.:“在临床病例中获取玻璃体液的收集系统”眼科档案。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hasebe,T.,et al.: "Molecular cloning of proteins proteins synthesized by alkaliburned rabbit corneas" Cornea. (1991)
Hasebe,T.,et al.:“碱烧兔子角膜合成的蛋白质的分子克隆”角膜。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakazawa, M., et al.: "Management of diabetic retinopathy (in Japanese)" Sogo Rinsho. 40. 347-348 (1991)
Nakazawa, M., et al.:“糖尿病视网膜病变的治疗(日语)”Sogo Rinsho。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakazawa, M., et al.: "Ocular complications of Diabetes mellitus. (in Japanese)" Most Current MAnagement of Diabetes mellitus. Iyaku Journal. (1991)
Nakazawa, M., et al.:“糖尿病的眼部并发症。(日语)”最新的糖尿病管理。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
中沢 満(分担): "ベッドサイド眼科学(分担)色覚の生理・心理物理学" 南江堂,
Mitsuru Nakazawa(共同作者):“床边眼科(共同作者)色觉的生理学和心理物理学”Nankodo,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAMAI Makoto其他文献
TAMAI Makoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAMAI Makoto', 18)}}的其他基金
Establishment of a method for restoring vision using light-gated ion channels and the promotion of optogenetics
光门离子通道恢复视力方法的建立及光遗传学的推广
- 批准号:
21200022 - 财政年份:2009
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Evaluation of protective and adverse effects of gene transferred IPE cell transplantation on degenerative retinal diseases
基因转移IPE细胞移植对退行性视网膜疾病的保护作用和不良作用评价
- 批准号:
15390524 - 财政年份:2003
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TREATMENT OF RETINAL DEGENERATIVE DISIESE BY TRANSPLANTATION OF GENE TRANSFERRED CELLS
基因转移细胞移植治疗视网膜退行性疾病
- 批准号:
12357010 - 财政年份:2000
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration : basic and clinical research
自体虹膜色素上皮细胞移植治疗年龄相关性黄斑变性:基础和临床研究
- 批准号:
10307041 - 财政年份:1998
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Treatment of ischemic retinal injury by administration of various cytokines through vitreous cavity.
通过玻璃体腔施用各种细胞因子治疗缺血性视网膜损伤。
- 批准号:
07557109 - 财政年份:1995
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Basic research for clinical application of retina and optic nerve regeneration by transplantation
视网膜及视神经移植再生临床应用基础研究
- 批准号:
07307016 - 财政年份:1995
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Regeneration of pigment cells and basic and clinical study for treatment of age-related macular degeneration
色素细胞再生及治疗年龄相关性黄斑变性的基础与临床研究
- 批准号:
06404061 - 财政年份:1994
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Basic and clinical approach for analysis and treatment of the age related neovascular maculopathy
年龄相关性新生血管性黄斑病分析和治疗的基础和临床方法
- 批准号:
03404050 - 财政年份:1991
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Development of Image Processing System for Fundus Video-Angiography with Non-Stroboscopic Illumination
无频闪照明眼底视频血管造影图像处理系统的研制
- 批准号:
63870070 - 财政年份:1988
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B).
相似海外基金
Pathological analysis using transgenic rats that produce acute retinitis pigmentosa.
使用产生急性色素性视网膜炎的转基因大鼠进行病理分析。
- 批准号:
23K09034 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inflammation in MERTK-dependent retinitis pigmentosa
MERTK 依赖性色素性视网膜炎中的炎症
- 批准号:
10743622 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Rod photoreceptor regeneration in a zebrafish model of Retinitis Pigmentosa.
色素性视网膜炎斑马鱼模型中杆状光感受器的再生。
- 批准号:
10607557 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Mitigating retinitis pigmentosa based on a non-invasive rod energy-landscape biomarker
基于非侵入性棒状能量景观生物标志物减轻色素性视网膜炎
- 批准号:
10733154 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
To assess the engraftment of hESC-derived photoreceptors and their ability to restore vision in early and advanced stages of Retinitis Pigmentosa.
评估 hESC 来源的光感受器的植入及其在色素性视网膜炎早期和晚期恢复视力的能力。
- 批准号:
MR/X001687/1 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
NAC Attack,针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验
- 批准号:
10333382 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别:
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center
NAC Attack,一项针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验:OCT 阅读中心
- 批准号:
10593932 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别:
NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa
NAC Attack,一项针对色素性视网膜炎患者的 3 期、多中心、随机、安慰剂对照试验
- 批准号:
10593911 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别:
In-vivo gene therapy for Retinitis Pigmentosa
色素性视网膜炎的体内基因治疗
- 批准号:
10043370 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别:
Grant for R&D
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
NAC Attack,针对色素性视网膜炎的 3 期、多中心、随机、安慰剂对照试验
- 批准号:
10593947 - 财政年份:2022
- 资助金额:
$ 4.16万 - 项目类别: